15 insiders reported 184 Form 4 transactions for MapLight Therapeutics, Inc. (MPLT) over the past 18 months (most recent 2026-08-19). Recent activity: Kroeger Christopher A. (Chief Executive Officer) Buy 23,145 shares, Lillie James Woodruff (Chief Scientific Officer) Buy 7,730 shares, GILLIS JONATHAN (CAO and Interim CFO) Buy 6,020 shares, Hanson Kristopher (General Counsel) Buy 7,730 shares, Foff Erin Pennock (Chief Medical Officer) Buy 13,360 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Kroeger Christopher A. | Chief Executive Officer | Buy | 23,145 | $0 |
| 2026-08-19 | Lillie James Woodruff | Chief Scientific Officer | Buy | 7,730 | $0 |
| 2026-08-19 | GILLIS JONATHAN | CAO and Interim CFO | Buy | 6,020 | $0 |
| 2026-08-19 | Hanson Kristopher | General Counsel | Buy | 7,730 | $0 |
| 2026-08-19 | Foff Erin Pennock | Chief Medical Officer | Buy | 13,360 | $0 |
| 2026-08-19 | Kreitzer Anatol | Chief Discovery Officer | Buy | 6,020 | $0 |
| 2026-08-19 | GILLIS JONATHAN | CAO and Interim CFO | Buy | 2,222 | $0 |
| 2026-08-04 | Lillie James Woodruff | Chief Scientific Officer | Sell | 22,082 | $276,908 |
| 2026-07-28 | Cox Troy | Director | Buy | 15,620 | $148,702 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 4,699 | $173,581 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 5,356 | $193,512 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 4,510 | $166,599 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 5,545 | $200,341 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 6,979 | $255,850 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 1,592 | $59,604 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 1,476 | $55,261 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 2,833 | $104,963 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 600 | $21,906 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 14,140 | $533,078 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 16,969 | $638,204 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 200 | $7,678 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 900 | $34,353 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 7,464 | $273,630 |
| 2026-07-17 | Kroeger Christopher A. | Chief Executive Officer | Sell | 18,950 | $682,200 |
| 2026-07-17 | Foff Erin Pennock | Chief Medical Officer | Sell | 7,155 | $258,725 |
Source: SEC Form 4 filings · as of 2026-08-19